SuperworthCrescent Biopharma market cap CBIO
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $476.2M
- Highest close in our data
- $858.8M
- Feb 2018
Crescent Biopharma is worth $476.2M at the close on Oct 23, 2026, at $12.82 a share.
That is up 170% over the last year and up 384% over five years.
Its highest close in our data was $858.8M in Feb 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $476.2M | $124.2M | $775.6M | +178% |
| 2025 | $171.6M | $8.4M | $209.2M | +1026% |
| 2024 | $15.2M | $9.7M | $211.9M | −90% |
| 2023 | $152M | $68.7M | $182.4M | −4% |
| 2022 | $158.8M | $28.8M | $158.8M | +113% |
| 2021 | $74.5M | $74.5M | $195.1M | −59% |
| 2020 | $179.8M | $90.7M | $220.7M | −27% |
| 2019 | $247.2M | $136.9M | $561.2M | −37% |
| 2018 | $393.4M | $391.7M | $858.8M | −32% |
| 2017 | $576.5M | $91.7M | $588.2M | +310% |
| 2016 | $140.7M | $74.4M | $193.9M | +29% |
| 2015 | $108.9M | $107.5M | $167.5M | −24% |
| 2014 | $143.4M | $115M | $182.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Crescent Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| CBIOCrescent Biopharma | $476.2M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| NATRNatures Sunshine Products | $213.8M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Crescent Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.